The Business Research Company’s Specialty Generics Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Specialty Generics Global Market Report 2023 evaluates specialty generics market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The global specialty generics market size grew from .36 billion in 2022 to .5 billion in 2023 at a compound annual growth rate (CAGR) of 14.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The specialty generics market size is expected to grow to 5.91 billion in 2027 at a CAGR of 12.0%.
The specialty generics market segments in the report are: 1) By Route Of Administration: Injectables, Oral, Other Route Of Administration 2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication 3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies
Top 5 Major Key Players Are: Teva Pharmaceutical Industries Ltd Endo International plc Akorn Operating Company LLC Mylan N.V Mallinckrodt Pharmaceuticals
Table Of Contents 1. Executive Summary 2. Specialty Generics Market Characteristics 3. Specialty Generics Market Trends And Strategies 4. Specialty Generics Market - Macro Economic Scenario 5. Specialty Generics Market Size And Growth ....... 26. Africa Specialty Generics Market 27. Specialty Generics Market Competitive Landscape And Company Profiles 28. Key Mergers And Acquisitions In The Specialty Generics Market 29. Specialty Generics Market Future Outlook and Potential Analysis 30. Appendix
Learn About Us: The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.